Nick Verber

Value of systematic genetic screening of patients with amyotrophic lateral sclerosis

Stephanie Shepheard, Matthew Parker, Johnathan Cooper‐Knock et al. · Journal of Neurology Neurosurgery & Psychiatry · 2021 · 115 citations · Full text

Life Sciences, Genetics, Neurology +14

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

Alexander G. Thompson, Elizabeth Gray, Nick Verber et al. · Brain Communications · 2022 · 81 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial

Gilbert Bensimon, P. Nigel Leigh, Timothy Tree et al. · The Lancet · 2025 · 32 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +16

Neuropathological characterization of a novel TANK binding kinase (<i>TBK1</i>) gene loss of function mutation associated with amyotrophic lateral sclerosis

Michael Weinreich, Stephanie Shepheard, Nick Verber et al. · Neuropathology and Applied Neurobiology · 2019 · 19 citations

Medicine, Molecular Genetics, Neurology +17

Long-Term Tofersen in <i>SOD1</i> Amyotrophic Lateral Sclerosis

Timothy M. Miller, Merit Cudkowicz, Pamela Shaw et al. · JAMA Neurology · 2026 · 11 citations · Full text

Life Sciences, Neurology, Neuroscience +17